3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is ever more attracting scientific scrutiny due to sparse information suggesting unique pharmacological characteristics. Current analyses suggest that 3-HPC may possess separate effects on the brain nervous system, arguably influencing to some of the unanticipated manifestations r